2004
DOI: 10.1097/01376517-200406000-00002
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective Study of Adherence to Glatiramer Acetate in Individuals with Multiple Sclerosis*

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
33
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(35 citation statements)
references
References 19 publications
2
33
0
Order By: Relevance
“…Studies included in this review varied in terms of the patient population, with 11 studies examining patients with RRMS only, 16,23,[25][26][27][28][29][30][31][32][33] 12 studies examining patients with any form of MS, 17,18,[34][35][36][37][38][39][40][41][42][43] and only 1 study examining the progressive form of the disease exclusively. 44 Among studies reporting time since MS diagnosis, mean time since diagnosis ranged between 2 and 12 years.…”
Section: ■■ Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Studies included in this review varied in terms of the patient population, with 11 studies examining patients with RRMS only, 16,23,[25][26][27][28][29][30][31][32][33] 12 studies examining patients with any form of MS, 17,18,[34][35][36][37][38][39][40][41][42][43] and only 1 study examining the progressive form of the disease exclusively. 44 Among studies reporting time since MS diagnosis, mean time since diagnosis ranged between 2 and 12 years.…”
Section: ■■ Resultsmentioning
confidence: 99%
“…All prospective studies included patients who were already on some form of DMT prior to assessing adherence (mean years on therapy ranged from 2 to 6 years across studies). [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39]44 Three retrospective studies evaluated adherence specifically among those initiating a DMT, 17,40,42 while the remaining 5 either did not specify prior treatment or included patients who had already received treatment with a DMT. 16,18,41,43 There were 6 different measures used in the literature to measure patient adherence, including 2 variations of the medication possession ratio (MPR; used among 11 studies), the missed dose ratio (MDR; 3 studies), total number of missed doses (2 studies), percentage of days not covered by therapy (2 studies), and no missed doses over a pre-specified time period (7 studies).…”
Section: ■■ Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The improvement of self-care ability is important in treatment of a chronic disease such as diabetes, and it increases the quality of life in diabetics (Fraser et al, 2004 should be taken into account because some studies consider the lack of daily self-care as the most important cause of mortality in diabetics (Halipchuk et al, 2017). Therefore, it is important to stimulate the self-care in these patients and use this potential (Afshar & Izadi, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…According to Bandura, self-efficacy is the highest predictive factor of perseverance in a new behavior. There is considerable evidence that higher selfefficacy is related to greater persistence in diverse contexts ranging from health recommendations for management of diabetes and rheumatoid arthritis, to exercise and smoking cessation programs, to medication taking in a variety of diseases such as epilepsy, HIV, post-transplantation [15] and RRMS [4,16].…”
Section: Self-efficacymentioning
confidence: 99%